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ntegrins regulate cell adhesion and motility through
tyrosine kinases, but initiation of this process is poorly
understood. We ﬁnd here that Src associates constitutively
with integrin 
 
 
 
IIb
 
 
 
3 in platelets. Platelet adhesion to ﬁbrino-
 
gen caused a rapid increase in 
 
 
 
IIb
 
 
 
3-associated Src activity,
and active Src localized to ﬁlopodia and cell edges. Csk,
which negatively regulates Src by phosphorylating Tyr-529,
was also constitutively associated with 
 
 
 
IIb
 
 
 
3. However,
ﬁbrinogen binding caused Csk to dissociate from 
 
 
 
IIb
 
 
 
3,
concomitant with dephosphorylation of Src Tyr-529 and
phosphorylation of Src activation loop Tyr-418. In contrast
to the behavior of Src and Csk, Syk was associated with
I
 
 
 
IIb
 
 
 
3 only after ﬁbrinogen binding. Platelets multiply
deﬁcient in Src, Hck, Fgr, and Lyn, or normal platelets treated
with Src kinase inhibitors failed to spread on ﬁbrinogen.
Inhibition of Src kinases blocked Syk activation and inhibited
phosphorylation of Syk substrates (Vav1, Vav3, SLP-76)
implicated in cytoskeletal regulation. Syk-deﬁcient platelets
exhibited Src activation upon adhesion to ﬁbrinogen, but
no spreading or phosphorylation of Vav1, Vav3, and SLP-76.
These studies establish that platelet spreading on ﬁbrinogen
requires sequential activation of Src and Syk in proximity
to 
 
 
 
IIb
 
 
 
3, thus providing a paradigm for initiation of integrin
signaling to the actin cytoskeleton.
 
Introduction
 
Outside-in signaling refers to the process whereby ligation of
an integrin adhesion receptor by a cognate ligand stimulates
inward signals that affect a variety of cellular responses,
including cytoskeletal reorganization, proliferation, differen-
tiation, and apoptosis (Aplin et al., 1998; Giancotti and
Ruoslahti, 1999; Geiger et al., 2001; Schwartz, 2001). Tyro-
sine phosphorylation of proteins is a major outside-in signaling
event, implying that there are key relationships between in-
tegrins and specific protein tyrosine kinases and phos-
phatases. In this regard, Src family kinases have been shown
to play a significant role in several phases of outside-in
signaling in many cell types (Kaplan et al., 1995; Lowell et
al., 1996; Schlaepfer and Hunter, 1997; Klinghoffer et al.,
1999; Suen et al., 1999; Feng et al., 2001; Suzuki-Inoue et
al., 2001; Timpson et al., 2001). A prominent example is in
adherent fibroblasts, where Src forms a complex with tyro-
sine-phosphorylated focal adhesion kinase (FAK),* and
where downstream effectors of this signaling complex regu-
late cell growth, migration, and focal adhesion turnover
(Guan, 1997; Polte and Hanks, 1997; Schlaepfer et al.,
1997; Schaller et al., 1999). Since formation of the Src–FAK
complex occurs at actin-rich adhesion sites that assemble
over minutes to hours, it is likely to be preceded by integrin-
dependent signals that are required for actin polymerization
and reorganization. However, the process by which integrins
initiate outside-in signaling is poorly understood.
Blood platelets are frequently used to study outside-in
signaling because they represent a physiologically important
cell, and the platelet-specific integrin, 
 
 
 
IIb
 
 
 
3, is required
for hemostasis. Outside-in signaling in platelets is triggered
when fibrinogen or von Willebrand factor binds to 
 
 
 
IIb
 
 
 
3,
and it is dependent on close functional, if not physical,
relationships between 
 
 
 
IIb
 
 
 
3 and the signaling machinery
of the cell (Shattil et al., 1998). Signals transduced by
 
 
 
IIb
 
 
 
3 regulate platelet filopodial extension, spreading,
aggregation, and granule secretion (Shattil et al., 1998; Phillips
et al., 2001). Since these responses involve polymerization
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and rearrangements of actin filaments (Fox, 1993; Hartwig et
al., 1999), 
 
 
 
IIb
 
 
 
3 signals presumably regulate actin dynamics.
Specific nonreceptor tyrosine kinases have been impli-
cated in 
 
 
 
IIb
 
 
 
3 outside-in signaling (Jackson et al., 1996;
Shattil et al., 1998; Phillips et al., 2001). For example, Syk
becomes activated within seconds of fibrinogen binding to
platelets, whereas FAK becomes activated later during plate-
let aggregation and spreading (Lipfert et al., 1992; Clark et
al., 1994). Syk activation does not require actin polymeriza-
tion since it is unaffected by inhibitors such as cytochalasin
D, whereas FAK activation requires actin polymerization
(Lipfert et al., 1992; Clark et al., 1994). Thus, activation of
Syk, but not FAK, may be a key early event in outside-in sig-
naling. This idea is supported by several recent observations.
First, platelet adhesion to fibrinogen stimulates a direct in-
teraction of Syk with the cytoplasmic tail of 
 
 
 
3, correlating
with Syk activation (Woodside et al., 2001). Second, Syk
heterologously expressed in CHO cells is activated in re-
sponse to clustering of 
 
 
 
IIb
 
 
 
3 complexes (Hato et al.,
1998). Third, adhesion of platelets or 
 
 
 
IIb
 
 
 
3-CHO cells to
fibrinogen induces Syk-dependent tyrosine phosphorylation
of proteins implicated in cytoskeletal regulation, including
Vav1 and SLP-76 (Cichowski et al., 1996; Judd et al., 2000;
Obergfell et al., 2001). The biological relevance of these in-
teractions for outside-in signaling in platelets is suggested by
studies of mice deficient in SLP-76, which exhibit a bleeding
diathesis and, among other platelet abnormalities, defective
spreading on fibrinogen (Clements et al., 1999; Judd et al.,
2000).
In addition to Syk and FAK, platelets contain several Src
family members (Src, Fyn, Fgr, Hck, Lyn, Yes), with Src it-
self being the most abundant (Golden et al., 1986; Huang et
al., 1991; Stenberg et al., 1997). Studies using chemical
cross-linking and immunoprecipitation techniques have sug-
gested that one or more Src kinases may be associated with
 
 
 
IIb
 
 
 
3, either before or after thrombin-induced platelet ac-
tivation (Dorahy et al., 1995; Kralisz and Cierniewski,
1998). Furthermore, Src becomes activated and partitions to
the detergent-insoluble actin cytoskeleton in thrombin-
aggregated platelets, suggesting that it is regulated by fibrin-
ogen binding to 
 
 
 
IIb
 
 
 
3 (Horvath et al., 1992; Clark and
Brugge, 1993; Fox et al., 1993).
Based on these considerations, we used biochemical and
genetic approaches here to determine how outside-in signal-
ing is initiated in platelets. The results establish that Src is
constitutively associated with 
 
 
 
IIb
 
 
 
3 and that platelet adhe-
sion to fibrinogen selectively activates this pool of Src, possi-
bly by inducing the dissociation of an Src-regulatory kinase,
Csk, from the 
 
 
 
IIb
 
 
 
3 complex. Furthermore, Src kinases
are required for 
 
 
 
IIb
 
 
 
3-dependent activation of Syk, and
both Src and Syk are required to initiate cytoskeletal events
responsible for platelet spreading on fibrinogen.
 
Results
 
Interactions between 
 
 
 
IIb
 
 
 
3 and Src in platelets
 
To begin to explore relationships between 
 
 
 
IIb
 
 
 
3 and Src
in outside-in signaling, we asked whether Src is associated
with 
 
 
 
IIb
 
 
 
3, either before or after platelet adhesion to fi-
brinogen, a response dependent on 
 
 
 
IIb
 
 
 
3. Human plate-
lets were incubated for 45 min over a BSA matrix, to which
they do not adhere, or a fibrinogen matrix, to which they
adhere and gradually spread. Then platelets were solubilized
in a buffer containing NP-40 detergent, the 
 
 
 
IIb
 
 
 
3 com-
plex was immunoprecipitated with a polyclonal antibody to
 
 
 
3, and immunoprecipitates were probed on Western blots
with an antibody to Src. As shown in Fig. 1 A, Src was de-
tected in 
 
 
 
3 immunoprecipitates whether or not the plate-
lets had become adherent to fibrinogen. The same results
were obtained if A2A9, an 
 
 
 
IIb
 
 
 
3 complex–dependent anti-
body, was used to immunoprecipitate the integrin (unpub-
lished data). A comparison of the Src that did and did not
quantitatively coprecipitate with 
 
 
 
IIb
 
 
 
3 indicated that
 
 
 
3% of the Src solubilized from platelets was associated
with 
 
 
 
IIb
 
 
 
3. Fyn and Yes, the only other Src family mem-
bers tested, were also associated with 
 
 
 
IIb
 
 
 
3 (Fig. 1 A).
Note in Fig. 1 A that the amounts of 
 
 
 
3 and Src were
slightly less in 
 
 
 
3 immunoprecipitates from adherent plate-
lets compared with nonadherent ones. This was attributed
to a minor redistribution of these proteins to the detergent-
insoluble actin cytoskeleton because it was prevented by pre-
incubation of platelets with 10 
 
 
 
M cytochalasin D to in-
hibit actin polymerization (see Fig. 2 A).
Two other nonreceptor protein tyrosine kinases, Pyk2 and
Btk, were not present in 
 
 
 
3 immunoprecipitates, and FAK
was present to a relatively minor degree despite being well
represented in the detergent-soluble lysate (Fig. 1 A). The
specificity of the Src association with 
 
 
 
IIb
 
 
 
3 was supported
Figure 1. Association of tyrosine kinases 
with  IIb 3. (A) Washed human platelets 
were plated on fibrinogen (Fib) for 45 
min or maintained in suspension in a 
BSA-coated dish (BSA). Cells were then 
lysed in NP-40 detergent, the detergent-
soluble fraction was immunoprecipitated 
with an antibody to  3 or normal rabbit 
serum (NRS) as a control, and immuno-
precipitates were probed on Western 
blots with antibodies to Src and other 
tyrosine kinases, as indicated. (B) Plate-
lets in suspension (BSA) were lysed in 
NP-40, and the presence of Src in  3 
and GP Ib  immunoprecipitates was 
compared. Results are representative 
of five separate experiments. 
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further by the observation that Src could not be detected in
immunoprecipitates of GP Ib
 
 
 
, another prominent platelet
adhesion receptor (Fig. 1 B). Csk, an Src-like tyrosine kinase
that has been implicated in the negative regulation of Src
family members (Okada et al., 1991; Latour and Veillette,
2001), was found to be associated with 
 
 
 
IIb
 
 
 
3 in suspended
platelets but not adherent ones (Fig. 1 A). These results re-
veal a specific and constitutive interaction between Src and
 
 
 
IIb
 
 
 
3 that is unaffected by platelet adhesion to fibrinogen,
and an interaction between Csk and 
 
 
 
IIb
 
 
 
3 that is dis-
rupted by adhesion.
To determine whether platelet adhesion to fibrinogen af-
fects the activation state of Src, Western blots of 
 
 
 
IIb
 
 
 
3
immunoprecipitates were probed with phospho-specific
antibodies to Src tyrosine residues 418 and 529. Autophos-
phorylation of Tyr-418 within the kinase activation loop is a
marker of Src activation. On the other hand, phosphoryla-
tion of Tyr-529 (the target residue of Csk) promotes in-
tramolecular interactions of the Src COOH terminus with
the SH2 domain, effectively inhibiting kinase activity (Xu et
al., 1999; Young et al., 2001). Thus, phosphorylation at
Tyr-529 is a marker of Src suppression. Platelet adhesion to
fibrinogen for 45 min caused a simultaneous increase in the
phosphorylation of Src Tyr-418 and a decrease in the phos-
 
phorylation Tyr-529 (Fig. 2 A). This effect was observed
within 15 min, the earliest time point at which sufficient
numbers of adherent platelets could be analyzed (unpub-
lished data). Src activation in fibrinogen-adherent platelets
was unaffected by 10 
 
 
 
M cytochalasin D, implying that it
did not require actin polymerization (Fig. 2 A). Adhesion-
dependent tyrosine phosphorylation of FAK was blocked by
cytochalasin D, as reported previously (Fig. 2 B) (Lipfert et
al., 1992). In contrast to these results for integrin-associated
Src, the bulk of the Src in platelets that did not coprecipitate
with 
 
 
 
IIb
 
 
 
3 failed to become activated during platelet adhe-
sion to fibrinogen (Fig. 2 C).
To analyze these results quantitatively, Src “activity” was ex-
pressed arbitrarily as the ratio of the phospho-specific Tyr-418
and Tyr-529 immunoblot signals after normalization for the
amount of Src in the 
 
 
 
3 immunoprecipitates (Fig. 2, D and
E). Platelet adhesion to fibrinogen caused a mean 35-fold in-
crease in Src activity as assessed by this method (
 
P
 
 
 
 
 
 0.02).
This effect was confirmed by direct measurements of Src ki-
nase activity in 
 
 
 
3 immunoprecipitates (
 
P
 
 
 
 
 
 0.001) (Fig. 2 F).
In contrast to platelet adhesion to immobilized fibrinogen,
binding of soluble fibrinogen to platelets requires prior activa-
tion of 
 
 
 
IIb
 
 
 
3. Therefore, to investigate whether soluble fi-
brinogen binding is sufficient to activate Src, platelets were in-
Figure 2. Effect of platelet adhesion to 
fibrinogen on Src activation. As described 
in the legend to Fig. 1, lysates from
fibrinogen-adherent and -nonadherent 
platelets were immunoprecipitated with 
an antibody to  3 (A) or FAK (B), and 
immunoprecipitates were probed on 
Western blots as indicated. (C) An 
analysis of the pool of Src that did not 
coimmunoprecipitate with  IIb 3 after 
two sequential immunoprecipitations 
with the anti- 3 antibody. In all panels, 
platelets were pretreated for 10 min with 
buffer, cytochalasin D (CD), or diluent 
(DMSO) before plating. (D) The raw data 
from the single experiment in A as Src 
“activity” associated with  3, expressed 
as the normalized ratio of Src pTyr-418/
pTyr-529. (E) The means   SEM of this 
ratio for five experiments. (F) The effects 
of platelet adhesion on Src activity in  3 
immunoprecipitates, measured by an in 
vitro kinase assay as described in Materials 
and methods. Results represent means   
SEM of four experiments.268 The Journal of Cell Biology | Volume 157, Number 2, 2002
cubated in the presence of 250  g/ml fibrinogen, and 0.5 mM
MnCl2 was added to directly activate  IIb 3 (Bazzoni and
Hemler, 1998). Fibrinogen binding caused both the dissocia-
tion of Csk from the  IIb 3 complex and the increased phos-
phorylation of Src Tyr-418 (Fig. 3, Fib   Mn
2  lane). These
responses were observed as early as 1 min, were stable for at least
20 min, and were blocked by 2 mM RGDS, which inhibits fi-
brinogen binding to  IIb 3. Interestingly, MnCl2 or RGDS
each induced a small amount Csk dissociation and Src Tyr-418
phosphorylation, suggesting that both integrin activation and
ligation contribute to Src activation (Fig. 3). Together with the
data for adherent platelets, these results establish that fibrinogen
binding to  IIb 3 causes dissociation of Csk from the  IIb 3
complex at the same time that the integrin-associated pool of
Src becomes activated. These responses require neither actin
polymerization nor tyrosine phosphorylation of FAK.
The results presented so far are consistent with the idea that
Src activation may occur in localized regions of the platelet
where  IIb 3 first comes in contact with fibrinogen. There-
fore, the distribution of activated Src in fibrinogen-adherent
platelets was determined by confocal microscopy using the
anti–pTyr-418 antibody as a marker. Although this antibody
may also react with the corresponding activation loop phos-
photyrosine of other Src family members, it reacted on West-
ern blots of platelet lysates with an apparent single band at
 60 kD, consistent with Src (unpublished data). Anti–pTyr-
418 antibody staining was confined to the filopodia and edges
of spreading platelets and to a central region corresponding to
the granulomere. In contrast, the distribution of “total” Src
determined with antibody 327 was more diffuse (Fig. 4).
Thus, Src activation takes place in association with  IIb 3
and at the periphery of spreading platelets.
Role of Src family kinases in outside-in signaling 
through  IIb 3
To determine whether an Src kinase is required for  IIb 3-
dependent cytoskeletal changes, platelets were preincubated
for 30 min with PP2, an inhibitor of Src family kinases
(Hanke et al., 1996), and then plated on fibrinogen. PP3, an
inactive analogue of PP2, was used as a control. 5  M PP2
abolished adhesion-dependent tyrosine phosphorylation of
Src Tyr-418 in  3 immunoprecipitates, but not phosphory-
lation of Tyr-529 or the association of Src with  IIb 3 (Fig.
5). Control platelets adherent to fibrinogen underwent mor-
phological changes ranging from filopodia protrusion to
complete spreading, with F-actin and tyrosine-phosphory-
lated proteins evident at the cell periphery. In contrast,
platelets treated with 5  M PP2 generally showed fewer and
smaller filopodia and spread very poorly (Fig. 6 A). The dif-
ferences in spreading between PP2-treated and control plate-
lets were significant as assessed by computerized image anal-
ysis of cell surface areas (P   0.001). Although not shown,
results identical to those with PP2 were obtained with 2  M
SU6656, a pharmacologically distinct, selective inhibitor of
Src family kinases (Blake et al., 2000). Furthermore, the
spreading defect of platelets treated with PP2 or SU6656
could be overcome if the cells were stimulated during adhe-
sion with a combination of agonists to G protein–coupled
receptors (1 mM PAR-4 receptor–activating peptide, 50
 M ADP, and 50  M epinephrine).
To address the role of Src kinases without using chemical
inhibitors, mouse bone marrow chimeras deficient in Src
family members were generated. Murine platelets are smaller
Figure 3. Effect of soluble fibrinogen binding to platelets on 
 IIb 3-associated Csk and Src. Platelets were incubated as indicated 
in the presence or absence of 250  g/ml fibrinogen, 0.5 mM MnCl2, 
and 2 mM RGDS for 20 min. Then the presence of Csk and Src in 
 3 immunoprecipitates was analyzed as described in the legends to 
Figs. 1 and 2. Results are representative of two experiments.
Figure 4. Distribution of activated Src and total Src in fibrinogen-
adherent platelets. Cells were plated on fibrinogen-coated coverslips 
for 45 min and prepared for confocal microscopy as described in 
Materials and methods. Images represent four platelets in various 
stages of spreading. In the merged images, activated Src (Src pTyr-418) 
is red and total Src is green. Arrowheads point to some of the filopodia 
that stained heavily for activated Src. The results are from a single 
experiment representative of three so performed. Bar, 10  m.Tyrosine kinases and integrin signaling | Obergfell et al. 269
than their human counterparts and spread less well on fi-
brinogen (Judd et al., 2000). Nonetheless, adherent wild-
type platelets exhibited filopodial extensions, variable de-
grees of spreading, and tyrosine-phosphorylated proteins.
The same was true for platelets lacking three Src kinases
(Fgr, Hck, and Lyn). In sharp contrast, platelets deficient in
Src as well as Fgr, Hck, and Lyn spread poorly on fibrinogen
and exhibited minimal tyrosine phosphorylation (Fig. 6 B).
Analysis of cell surface areas confirmed that the spreading
defect of these latter platelets was significant (P   0.0001).
Thus, Src and possibly other Src family members are in-
volved in  IIb 3-dependent platelet spreading.
To identify potential downstream effectors of  IIb 3 and
Src, the effect of PP2 or SU6656 on adhesion-dependent ty-
rosine phosphorylation of several platelet proteins was exam-
ined. The results with PP2 are shown in Fig. 7 and are iden-
tical to those obtained with SU6656. PP2, but not PP3,
inhibited adhesion-dependent tyrosine phosphorylation of
Syk (Fig. 7 A), tyrosine phosphorylation of putative Syk
substrates Vav1, Vav3, and SLP-76, and tyrosine phosphor-
ylation of SLAP-130, an adaptor that binds to SLP-76 (Fig.
7 B) (Judd et al., 2000; Obergfell et al., 2001). On the other
hand, PP2 had no effect on the adhesion-dependent associa-
tion of Syk with  IIb 3 (Fig. 7 C). Thus, one or more Src
family kinases appear to be required for  IIb 3-dependent
activation of Syk and for tyrosine phosphorylation of Syk
substrates implicated in cytoskeletal regulation (Judd et al.,
2000; Obergfell et al., 2001).
Role of Syk in outside-in signaling through  IIb 3
Platelets genetically deficient in Syk were evaluated to estab-
lish if Syk was required for either Src activation or for cy-
toskeletal changes that promote platelet spreading. The peri-
natal lethality of syk
 /  mice was overcome by generation of
syk
 /   bone marrow chimeras. Compared with wild-type
platelets, syk
 /  platelets displayed fewer and less prominent
filopodia, reduced tyrosine phosphorylation, and less spread-
ing and (P   0.001) (Fig. 8). However, when syk
 /  plate-
lets were stimulated during the adhesion process with a com-
bination of PAR-4 receptor–activating peptide, ADP, and
epinephrine, they now spread fully and exhibited tyrosine
phosphorylation at cell edges (Fig. 8). As expected, syk
 / 
platelets spread poorly on fibrinogen when stimulated with
collagen, which activates platelets in part through an Syk-
coupled receptor, GP VI/FcR   (Watson and Gibbins,
1998). Thus, Syk is required for platelet spreading mediated
by outside-in signaling through  IIb 3. However, spread-
ing can occur in a manner independent of Syk if platelets are
costimulated with agonists to G protein–coupled receptors.
To identify platelet proteins whose tyrosine phosphoryla-
tion is dependent on Syk, syk
 /  platelets were subjected to
immunoprecipitation and Western blot analysis. Compared
with wild-type platelets, syk
 /  platelets exhibited virtually
Figure 5. Effect of PP2 on Src activity and Src association with 
 IIb 3. Platelets were preincubated for 30 min with PP2, plated on 
fibrinogen or suspended over BSA for 45 min, and Src in  IIb 3 
immunoprecipitates was analyzed as described in the legend to 
Fig. 1. Results are representative of two experiments.
Figure 6. Role of Src family kinases in 
platelet spreading on fibrinogen. (A) 
Human platelets were preincubated for 
30 min with buffer, 5  M PP2, or 5  M 
PP3. After adhesion to fibrinogen for 45 
min, cells were fixed, permeabilized, 
stained for F-actin (red) and phospho-
tyrosine (green), and analyzed by 
confocal microscopy. Arrowheads orient 
the reader to filopodia and arrows to the 
peripheral rims of some of the spreading 
platelets. Results are representative of 
three experiments. (B) Platelets from 
wild-type or chimeric mice were plated 
on fibrinogen for 45 min, stained as 
above, and analyzed by confocal 
microscopy. Note that murine platelets 
are smaller than human platelets. 
Bars, 10  m.270 The Journal of Cell Biology | Volume 157, Number 2, 2002
no adhesion-dependent tyrosine phosphorylation of Vav1,
Vav3, or SLP-76, and reduced tyrosine phosphorylation of
SLAP-130 (Fig. 9). In contrast, both the association of Src
with  IIb 3 and the adhesion-dependent activation of Src
were normal in syk
 /  platelets (Fig. 10). Altogether, these
results indicate that Syk is downstream of Src but upstream
of Vav1, Vav3, and SLP-76 in an  IIb 3 signaling pathway
that regulates the platelet actin cytoskeleton.
Discussion
Outside-in signaling through integrins mediates numerous
anchorage-dependent cellular responses (Aplin et al., 1998;
Giancotti and Ruoslahti, 1999; Schwartz, 2001). Compo-
nents of the actin cytoskeleton are particularly important
targets of integrin signals because they are often concen-
trated within integrin-based adhesion structures known as
focal complexes and focal adhesions, and they participate in
the regulation of cell shape and gene expression (Schoen-
waelder and Burridge, 1999; Geiger et al., 2001). In adher-
ent cells, an increase in tyrosine phosphorylation of cytoskel-
etal and signaling proteins is one of the most prominent
events within actin-rich filopodia, lamellipodia, and focal
adhesions (Hall, 1998; Geiger et al., 2001; Schwartz, 2001).
In fibroblasts, the cell types most commonly studied in this
regard, Src and FAK, have been identified as a prominent
signaling complex that functions downstream of integrins to
regulate cell migration and focal adhesion turnover (Guan,
1997; Polte and Hanks, 1997; Schlaepfer et al., 1997;
Schaller et al., 1999). In hematopoietic cells, including
platelets, Syk has been identified as a third type of tyrosine
kinase that is activated by integrins (Clark et al., 1994; Lin
et al., 1995). In fact, platelet adhesion to fibrinogen stimu-
lates both the direct association of Syk with the cytoplasmic
tail of  3 and Syk activation (Woodside et al., 2001). Un-
like activation of FAK, Syk activation in adherent platelets
precedes actin polymerization, and Syk substrates, including
Vav1 and SLP-76, have been implicated in cytoskeletal regu-
lation (Miranti et al., 1998; Judd et al., 2000; Obergfell et
al., 2001). Therefore, Syk may participate in the initiation of
 IIb 3-dependent actin polymerization and platelet spread-
Figure 7. Effect of inhibition of Src kinases on Syk and its substrates. 
Platelets were processed as described in the legends to Figs. 1 and 
5. (A) The effect of 5  M PP2 on tyrosine phosphorylation of Syk. 
(B) The effect on tyrosine phosphorylation of Vav1, Vav3 and 
SLP-76. (C) The effect on adhesion-dependent association of Syk 
with  IIb 3. Results are representative of two experiments.
Figure 8. Platelet spreading on fibrinogen is defective in syk
 /  
murine platelets. Platelets were obtained from syk
 /  and wild-type 
mice and plated on fibrinogen for 45 min with no agonist; with a 
combination of PAR-4 receptor–activating peptide (1 mM), ADP 
(50  M), and epinephrine (50  M); or with collagen (10  g/ml). 
Cells were then fixed, permeabilized and stained for F-actin (red) 
and phosphotyrosine (green), and analyzed by confocal microscopy. 
Arrowheads point to filopodia and arrows to the peripheral rims of 
some of the spreading platelets. Results are representative of three 
experiments. Bar, 10  m.Tyrosine kinases and integrin signaling | Obergfell et al. 271
ing. Src is also activated during platelet aggregation (Clark
and Brugge, 1993), but its precise role in outside-in signal-
ing in platelets has not been established.
Human- and gene-targeted mouse platelets were used here
to define the relationships between  IIb 3, Src, and Syk in
outside-in signaling. The major new findings are: (a) Src and
its regulatory kinase, Csk, are constitutively associated with
 IIb 3 in resting platelets. (b) Upon soluble fibrinogen
binding to  IIb 3 or platelet adhesion to immobilized fi-
brinogen, Csk dissociates from  IIb 3 and Src becomes ac-
tivated, independent of actin polymerization. Activated Src
localizes to the periphery of spreading platelets, including
filopodia. (c) The activity of Src is required for  IIb 3-
dependent tyrosine phosphorylation of Syk and for platelet
spreading on fibrinogen. (d) Syk is also required for platelet
spreading but not for Src activation. Thus, outside-in signal-
ing in platelets is initiated by the sequential activation of Src
and Syk in proximity to  IIb 3, providing a molecular basis
for signal generation from  IIb 3 to the actin cytoskeleton.
Immunoprecipitation analysis of NP-40 detergent extracts
revealed that Src and the related kinases, Fyn and Yes, were
associated with  IIb 3, both before and after platelet adhe-
sion to fibrinogen. These interactions are specific because no
association was observed between  IIb 3 and two other
nonreceptor tyrosine kinases, Pyk2 and Btk. Furthermore,
Src did not coprecipitate with GP Ib , another abundant
platelet membrane adhesion receptor (Fig. 1). These results
are consistent with a brief report that Src coprecipitates with
 IIb 3 from Triton X-100 lysates of resting platelets (Kral-
isz and Cierniewski, 1998). In another study, Dorahy et al.
(1995) detected association of Src (and Lyn) with  IIb 3,
but only in the presence of a cell-permeable chemical cross-
linker which simultaneously activated the platelets. Our
ability to detect Src, Fyn, and Yes in  IIb 3 immunoprecip-
itates without cross-linkers reflects differences in the condi-
tions used for platelet preparation and analysis. Although we
did not analyze  IIb 3 immunoprecipitates for all Src fam-
ily members expressed in platelets, these results indicate that
Src associates with and is regulated by  IIb 3, and this
functional relationship may extend to some other Src family
members.
These studies do not resolve whether the association of Src
with  IIb 3 is direct or indirect. Several proteins are capa-
ble of binding directly to the cytoplasmic tails of  IIb or  3
in vitro, and one of these might serve to link Src to  IIb 3
in platelets (Shattil et al., 1998; Liu et al., 2000; Phillips et
al., 2001). FAK and Syk warrant discussion in this regard.
FAK can bind to peptides derived from integrin   tails
(Schaller et al., 1995), and we found it to be associated with
 IIb 3 in platelet lysates (Fig. 1). Furthermore, when FAK
becomes auto-phosphorylated at Tyr-397 in adherent fibro-
blasts, it forms a bimolecular complex with Src (Guan,
1997; Polte and Hanks, 1997; Schaller et al., 1999; Schaller,
2001). However, a FAK–Src complex cannot mediate the
interaction we observed between  IIb 3 and Src in platelets
because, in contrast to FAK activation, the  IIb 3/Src asso-
ciation was neither adhesion-dependent nor inhibited by cy-
tochalasin D (Fig. 2 B). Syk is also unlikely to serve as a nec-
essary link between Src and  IIb 3 because it coprecipitated
with the integrin only after platelet adhesion (Fig. 1), even
in Syk-null platelets (Fig. 10) (Woodside et al., 2001). The
precise mode of interaction between  IIb 3 and Src re-
mains to be determined.
How does fibrinogen binding to  IIb 3 lead to activation
of Src? Src is stabilized in an inactive conformation by in-
tramolecular interactions of the SH2 domain with pTyr-529
and the SH3 domain with a polyproline helix in the SH2 ki-
nase linker region (Xu et al., 1999; Young et al., 2001). Tyr-
529 is likely maintained in the phosphorylated state by Csk
(Okada et al., 1991; Latour and Veillette, 2001), a kinase that
was associated with  IIb 3 in nonadherent platelets. Fibrino-
gen interaction with platelets resulted in the dissociation of
Csk (but not Src) from  IIb 3 (Figs. 1 and 3), suggesting that
Src may become activated at integrin adhesion sites following
its physical separation from Csk. This idea is consistent with
Figure 9. Effect of Syk deficiency on adhesion-dependent tyrosine 
phosphorylation in platelets. After plating on BSA or fibrinogen for 
45 min, wild-type and syk
 /  platelets were subjected to immuno-
precipitation and Western blotting as indicated. Results are 
representative of three experiments.
Figure 10. Effect of Syk deficiency on adhesion-dependent activation 
of Src. Wild-type and syk
 /  platelets were plated on fibrinogen or 
suspended over BSA for 45 min, and  3 immunoprecipitates were 
analyzed on Western blots as indicated. Results are representative 
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the localization of activated Src to filopodia and edges of fi-
brinogen-adherent platelets (Fig. 4), and with the observation
that only the integrin-associated pool of Src became activated
in such platelets (Fig. 2). In T lymphocytes, the proximity of
Csk to Src kinases is influenced by specific transmembrane
proteins, such as PAG/Cbp, which are enriched in lipid rafts
and bind Csk when tyrosine-phosphorylated (Brdicka et al.,
2000; Kawabuchi et al., 2000). PAG/Cbp is also present in
platelets (Watson et al., 2001), but additional studies will be
required to determine if it is involved in regulating the associa-
tion of Csk with  IIb 3. Fibrinogen binding to platelets
might also activate Src by influencing the localization or activ-
ity of a protein tyrosine phosphatase that can dephosphorylate
Src Tyr-529. Three such phosphatases have been implicated in
integrin signaling in other cell types, including receptor-like
protein-tyrosine phosphatase- , PTP-1B, and SHP-2 (Oh et
al., 1999; Su et al., 1999; Cheng et al., 2001). In theory, Src
might also be subject to regulation in platelets by proteins
within nascent adhesion sites that engage the Src SH2 or SH3
domains (Xu et al., 1999; Young et al., 2001).
The results with PP2 and SU6656 strongly suggest that
 IIb 3-dependent tyrosine phosphorylation of Syk and
platelet spreading on fibrinogen are controlled by an Src ki-
nase. The defect in spreading of murine platelets lacking Src,
Fgr, Hck, and Lyn confirms this assessment, and the normal
spreading of platelets lacking Fgr, Hck, and Lyn suggests
that Src itself plays a dominant role. However, the current
studies do not exclude the involvement of other Src family
members in specific phases of outside-in signaling.
PP2 and SU6656 blocked adhesion-dependent tyrosine
phosphorylation of the Rac exchange factors, Vav1 and
Vav3, and the molecular adaptor, SLP-76, all of which have
been implicated in cytoskeletal regulation downstream of in-
tegrins in hematopoietic cells (Fig. 7) (Cichowski et al.,
1996; Judd et al., 2000; Moores et al., 2000). Since these
proteins are direct substrates of Syk, the results imply that
Src kinases lie upstream of Syk in an  IIb 3 pathway, possi-
bly directly upstream. Although not studied, other substrates
of Src kinases and Syk, such as cortactin and tubulin, might
also couple  IIb 3 to cytoskeletal events (Gallet et al.,
1999; Faruki et al., 2000). Unlike Syk activation by immune
response receptors that contain ITAM domains,  IIb 3 ac-
tivation of Syk is ITAM-independent (Gao et al., 1997;
Turner et al., 2000; Woodside et al., 2001). Based on the
current results, we speculate that fibrinogen binding to
platelets induces clustering of  IIb 3 complexes, leading to
activation of Src kinases, interaction of Syk with the cyto-
plasmic tail of  3, and activation of Syk by the Src kinases.
Activation of additional Syk molecules might then proceed
by autophosphorylation in trans.
Syk
 /  mouse platelets have a very subtle defect in agonist-
induced fibrinogen binding (Law et al., 1999), and a pro-
found defect in aggregation induced by collagen (Watson
and Gibbins, 1998). These abnormalities cannot explain the
spreading defect we observed in fibrinogen-adherent syk
 / 
platelets (Fig. 8) because no agonists were added in this ex-
periment, and agonists are not required for platelet attach-
ment to immobilized fibrinogen via  IIb 3 (Savage et al.,
1992; Law et al., 1999). By the same token, neither Src nor
Syk were required for agonist enhancement of platelet
spreading on fibrinogen (Fig. 8). Like platelets, Syk-defi-
cient neutrophils exhibit defective integrin-dependent re-
sponses, such as the respiratory burst (unpublished data).
Although integrins and Src kinases are ubiquitous, Syk was
thought until recently to be confined to hematopoietic cells.
However, Syk is more widely distributed and may regulate the
anchorage-dependent growth of epithelial and endothelial
cells (Coopman et al., 2000; Inatome et al., 2001; Tsujimura
et al., 2001; Yamada et al., 2001). Moreover, Syk can interact
with integrin  1 and  2 tails as well as  3 (Woodside, D.,
and M. Ginsberg, personal communication), and our prelimi-
nary studies indicate that Src is associated with  1 integrins in
platelets. Consequently, some of the functions attributable to
Syk in hematopoietic and nonhematopoietic cells may require
coordinated interactions between integrins, Src, and Syk.
Thus, the paradigm delineated here for initiation of outside-in
 IIb 3 signaling in platelets may be relevant to integrins in a
variety of biological contexts.
Materials and methods
Reagents
Anti-Csk antibody was from Transduction Laboratories; anti-Src pTyr-418
and anti–Src-pTyr-529 from BioSource International, Inc. Anti-Src anti-
body 327 recognizes the SH3 domain of c-Src (Lipsich et al., 1983) (un-
published data). Antibody 2-7 to Yes was generated by immunization of
mice with the noncatalytic domain of Yes purified from E. coli extracts (Su-
dol and Hanafusa, 1986) (unpublished data). Antibodies to Fgr, Hck, Lyn,
Syk, and Vav1 were from Santa Cruz Biotechnology, Inc., and antibodies
to FAK, phosphotyrosine, Fyn, Btk, and Pyk2 were from Upstate Biotech-
nology. Antibody A2A9 is specific for  IIb 3 and antibody #8053 is spe-
cific the  3 subunit (a gift from Mark Ginsberg, La Jolla, CA, The Scripps
Research Institute, La Jolla, CA) (Bennett et al., 1983; Woodside et al.,
2001). Antibodies AP-1 and #3584 to GPIb  were from Tom Kunicki and
Zaverio Ruggeri (The Scripps Research Institute), respectively (Okita et al.,
1985; Vicente et al., 1990). Antibodies to SLP-76 and SLAP-130 were from
Gary Koretzky (University of Pennsylvania, Philadelphia, PA) (Motto et al.,
1996). Antiserum #2206 to Vav3 was produced by rabbit immunization
with a bacterially expressed GST-Vav3 fusion protein containing Vav3
amino acid residues 563–847. It did not cross-react with endogenous or
recombinant Vav1 or Vav2 by Western blotting. HRP-conjugated second-
ary antibodies were from Bio-Rad Laboratories. Texas red– and FITC-con-
jugated anti–mouse and anti–rabbit IgG were from Jackson ImmunoRe-
search Laboratories, Inc. Rhodamine-phalloidin was from Molecular
Probes; purified human fibrinogen was from Enzyme Research Laborato-
ries, Inc.; collagen, leupeptin, and cytochalasin D were from Sigma-
Aldrich, and sodium orthovanadate and sodium fluoride were from Fisher
Scientific. Protein A Sepharose was from Amersham Pharmacia Biotech;
Pefabloc and aprotinin were from Roche Molecular Biochemicals; PP2
and PP3 were from Calbiochem; and SU6656 was from SUGEN.
Bone marrow chimeras
src
 /  mice (Soriano et al., 1991) were bred to the hck
 / /fgr
 / /lyn
 / 
background (Meng and Lowell, 1997) and mated to obtain hck
 / /fgr
 / /
lyn
 / /src
 /  mutant embryos. hck
 / /fgr
 / /lyn
 / /src
 /  embryos were
generated from the same pregnancy. syk
 /  mice (Turner et al., 1995) were
mated to obtain Syk
 /  embryos. Fetuses were genotyped by PCR. Bone
marrow chimeras were generated by injecting mutant or wild-type litter-
mate fetal liver cells into lethally irradiated C57BL/6 recipients. Repopula-
tion of the hematopoietic compartment by transplanted cells was con-
firmed by absence of the relevant tyrosine kinase(s) in platelets, as
determined by Western blotting, and by absence of peripheral B-cells in
the syk
 /  chimeras, as determined by flow cytometry. Platelets from chi-
meras were studied 6–8 wk after transplantation. In some experiments,
syk
 /  rather than syk
 /  chimeras were used as controls, with no differ-
ences in results from these two sources.
Interactions of platelets with fibrinogen
Washed human platelets were obtained from fresh, anticoagulated whole
blood and resuspended to 3   10
8 cells/ml in a platelet incubation bufferTyrosine kinases and integrin signaling | Obergfell et al. 273
(Leng et al., 1998). To test the effects of soluble fibrinogen binding to
 IIb 3, platelets were incubated at room temperature for 15 min with 250
 g/ml fibrinogen in the presence or absence of 0.5 mM MnCl2 (to activate
integrins) (Bazzoni and Hemler, 1998) and 2 mM RGDS (to block fibrino-
gen binding). Platelets were then sedimented at 180 g for 5 min, washed
once with phosphate-buffered saline, and solubilized for 10 min on ice in
a buffer containing 0.5% NP-40, 50 mM NaCl, 50 mM Tris, pH 7.4 and in-
hibitors (1 mM sodium vanadate, 0.5 mM sodium fluoride, 0.5 mM leu-
peptin, 0.25 mg/ml Pefabloc, 100  g/ml aprotinin). Lysates were routinely
clarified by sedimentation at 10,000 rpm in a 4  microcentrifuge, and sub-
jected to immunoprecipitation and Western blotting. Identical results were
obtained if lysates were clarified at 100,000 g for 30 min. For studies of
platelet adhesion to fibrinogen, 100 mm bacterial tissue culture plates
were precoated with 5 mg/ml BSA or 100  g/ml fibrinogen (Haimovich et
al., 1993). After blocking with heat-denatured BSA, 4.5   10
8 platelets in
1.5 ml were added and incubated for the indicated periods of time at 37 C
in a CO2 incubator. Nonadherent cells from the BSA plates were sedi-
mented at 10,000 rpm for 3 s in a microcentrifuge and lysed immediately.
Platelets adherent to fibrinogen were gently rinsed twice in phosphate-
buffered saline, lysed on the plates directly and processed for immunopre-
cipitation and Western blotting.
For studies of mouse platelets, anticoagulated mouse blood was ob-
tained by cardiac puncture (Judd et al., 2000). Platelet preparation and ex-
perimental procedures were similar to those with human platelets.
Immunoprecipitation and Western blotting
500  l aliquots of each platelet lysate containing equal amounts of protein
(ranging from 500–750  g between experiments) were immunoprecipi-
tated with the indicated antibodies and protein A. Samples were electro-
phoresed in 7.5% SDS-polyacrylamide gels, transferred onto nitrocellulose
and subjected to Western blotting (Gao et al., 1997; Miranti et al., 1998).
Immunoreactive bands were detected by enhanced chemiluminescence
with reaction times ranging from 5 s to 5 min. Blots were scanned in a
Hewlett-Packard ScanJet 5300C scanner, and labeled bands were quanti-
fied by calibrated densitometry using NIH Image software.
Src Kinase Assay
 IIb 3 was immunoprecipitated from platelet lysates with antibody
#8053, and the protein A beads were washed twice. Beads were resus-
pended in kinase buffer and Src kinase activity was measured with a pep-
tide substrate (KVEKIGEGTYGVVYK) according to the manufacturer’s in-
structions (Src Assay Kit, Upstate Biotechnology Inc.)
Confocal microscopy
Washed human or mouse platelets were plated on fibrinogen-coated cov-
erslips for 45 min at room temperature. Adherent cells were fixed in 3.7%
formaldehyde, permeabilized with 0.1% Triton X-100, and stained with
primary and FITC- or Texas red–conjugated secondary antibodies as indi-
cated. Rhodamine-phalloidin was used to stain F-actin. Single images were
acquired with a Leica fluorescence microscope equipped with a laser
scanning confocal system (MRC 1024; Bio-Rad Laboratories). Images were
processed in Adobe Photoshop. Surface areas of at least 100 platelets per
sample were measured using Image-Pro Plus Software (Media Cybernetics,
Inc.). Statistical analyses were performed using Student’s t test.
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